Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.
Rocchetti M, et al.
Cardiovasc Res. 2014 Oct 1;104(1):37-48. doi: 10.1093/cvr/cvu188. Epub 2014 Aug 18.
Cardiovasc Res. 2014.
PMID: 25139747